New Approaches to Optimize Asparaginase Therapy in the Management of Acute Lymphoblastic Leukemia

Get up to date on the latest strategies for integrating asparaginase-containing chemotherapy regimens into the management of ALL in adolesent/young adult and adult patients with this educational program featuring an on-demand webcast and downloadable slidesets from a live CCO symposium along with a companion FAQ commentary where experts answer audience questions from the live program.

Share

Program Content

Activities

Pediatric ALL Tx for AYA and Adults
Applying Lessons and Experience in Pediatric Patients to the Treatment of AYA and Adult Patients With ALL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 06, 2022

Expires: June 05, 2023

Asparaginase Toxicities
Strategies to Mitigate Adverse Events With Asparaginase Treatment in Patients With ALL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 06, 2022

Expires: June 05, 2023

Asparaginase Hypersensitivity
Practical Considerations for Administration of Asparaginase-Based Therapy to Patients With ALL: Hypersensitivity or Intolerance or Inactivation?
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 07, 2022

Expires: June 06, 2023

No activities added yet

Activities

FAQ: Asparaginase in ALL
Asparaginase in AYA and Adult ALL: Expert Discussion of Frequently Asked Questions
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 23, 2022

Expires: August 22, 2023

Faculty

cover img faculity

Emily Curran, MD

Assistant Professor
Department of Internal Medicine
Division of Hematology and Oncology
University of Cincinnati Cancer Center
Cincinnati, Ohio

cover img faculity

Daniel J. DeAngelo, MD, PhD

Professor of Medicine
Harvard Medical School
Chief, Division of Leukemia
Dana-Farber Cancer Institute
Boston, Massachusetts

cover img faculity

Kjeld Schmiegelow, MD, DMSci

Professor
Department of Pediatric Oncology
Righospitalet University Hospital
Copenhagen, Denmark

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Jazz Pharmaceuticals, Inc.